Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
Lu Liu,Ling Zhou,Ling-Ling Wang,Peng-Dou Zheng,Feng-Qin Zhang,Zhen-Yu Mao,Huo-Jun Zhang,Hui-Guo Liu
DOI: https://doi.org/10.2147/jir.s417801
IF: 4.5
2023-07-01
Journal of Inflammation Research
Abstract:Lu Liu, 1, &ast Ling Zhou, 1, &ast Ling-Ling Wang, 1 Peng-Dou Zheng, 1 Feng-Qin Zhang, 1 Zhen-Yu Mao, 1 Huo-Jun Zhang, 2 Hui-Guo Liu 1 1 Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hui-Guo Liu; Huo-Jun Zhang, Email ; Bronchial asthma is a complex heterogeneous airway disease, which has emerged as a global health issue. A comprehensive understanding of the different molecular mechanisms of bronchial asthma may be an efficient means to improve its clinical efficacy in the future. Increasing research evidence indicates that some types of programmed cell death (PCD), including apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis, contributed to asthma pathogenesis, and may become new targets for future asthma treatment. This review briefly discusses the molecular mechanism and signaling pathway of these forms of PCD focuses on summarizing their roles in the pathogenesis and treatment strategies of asthma and offers some efficient means to improve clinical efficacy of therapeutics for asthma in the near future. Keywords: asthma, bronchial asthma, programmed cell death Asthma is a complex heterogeneous airway disease identified by pulmonary inflammation, airway hyperresponsiveness, mucus hypersecretion, and airway remodeling. 1 Asthma has become a global health challenge with more than 300 million patients worldwide. Due to its rising prevalence, 2 its sufferers may reach 400 million in 2025. 3 Although great improvement has been made in the treatment of asthma in recent decades, there are still 5% to 10% patients are suffering from uncontrollable severe asthma. 4 Asthma remains a great cause of heavy disease burden, including reduced quality of life and premature death at all ages. 5 Therefore, it is compulsory to further evaluate more effective treatment options for asthma. Fully comprehending the molecular mechanism of asthma may be an effective method to discover new drug targets and enrich asthma treatments. Figure 1 Signaling pathway of apoptosis. Intrinsic apoptotic pathway: Intracellular damage signals make mitochondrial outer membrane permeabilization (MOMP) release cytochrome C and the second mitochondria-derived activator of caspases (SMAC) into the cytoplasm. Cytochrome C integrates with apoptotic protease activating factor-1 (APAF-1) and pro-caspase - 9 to establish apoptosomes. In the apoptosomes, caspase-9 self-activates and reactivates the apoptotic "executioner" function of caspase-3/7. At the same time, SMAC impedes the function of inhibitors of apoptosis proteins (IAPs) and fosters apoptosis. BH3-only proteins can activate pro-apoptotic proteins and inhibit anti-apoptotic proteins, thereby fostering apoptosis. Extrinsic apoptotic pathway: after the death ligand binds to the death receptor, the death receptor interacts with the adapter protein FAS-associated protein with death domain (FADD) and recruits pro-caspase-8 to create the death-inducing signaling complex (DISC), and caspase-8 is activated, which can directly activate caspase-3/7, and can also cleave Bid into active tBID, thereby inducing MOMP-mediated apoptosis. Figure 2 Signaling pathway of Autophagy. Macroautophagy: When a mechanistic target of rapamycin complex 1 (mTORC1) is blocked or 5'-AMP-activated protein kinase (AMPK) is activated, the Unc-51-like kinase (unc-51-like kinase, ULK) complex activates and phosphorylates the PI3K3 complex to start the nucleation phase of the autophagosome. Under the action of ATG4, ATG7, and ATG3, microtubule-linked protein1 light chain 3 (LC3) transforms into mature LC3-II, isolating ubiquitin-like substances into evolving autophagy. The binding of ATG5, ATG12, and ATG16 further stimulate autophagic membrane elongation. Finally, the autophagosome membrane seals to create mature autophagosomes, which merge with a lysosome to form autolysosomes, and the contents of the autophagosome are degraded by lysosomal enzymes. PINK1/Parkin-mediated mitophagy: When mitochondria are damaged, the protein kinase PINK1 is blocked from entering the inner mitochondrial membrane, but accrues in the outer mitochondrial membrane and is activated by autophosphorylation, and then recruits and activates Parkin. Parkin ubiquitinates several mitochondrial membranes substrates on the mitochondrial outer membr -Abstract Truncated-
immunology